DarioHealth stock gets new chairman ahead of earnings call

Published on 11/05/2026 at 01:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DarioHealth stock gains a new chairman as the company targets the convergence of consumer and payer-funded care. Earnings follow next week.

Leadership change ahead of earnings

John R. Palumbo became DarioHealth's chairman effective November 3, succeeding Yoav Shaked.
Palumbo will join the November 12 earnings call to discuss consumer and payer-led healthcare.
DarioHealth is positioning its AI-powered platform across chronic conditions and provider-backed care.

DRIO, US23725P3082, Illustration mit AI erstellt.

DarioHealth has appointed John R. Palumbo as chairman of the board, effective Tuesday, November 3, 2026. The company announced the leadership change on Wednesday, November 4, in a PRNewswire release.

Board change sharpens strategic focus

Palumbo joined DarioHealth's board in April and succeeds Yoav Shaked, who remains a director after serving as chairman since 2018. The company said the change comes as consumer-directed healthcare and payer-funded chronic-care management increasingly overlap.

Palumbo brings more than four decades of healthcare operating experience. His previous roles included leadership positions at AmerisourceBergen, now Cencora, and chief operating officer at Allscripts Healthcare Solutions, now Veradigm. He also serves on the boards of PM Pediatrics Management Group, Lucid Diagnostics, ivWatch and Qless.

Earnings call sets next milestone

Palumbo is scheduled to join DarioHealth's conference call for third-quarter 2026 results on Thursday, November 12, at 8:30 a.m. Eastern Time. Management plans to discuss the board's view of changing healthcare markets and the company's strategic priorities.

DarioHealth's release describes a platform that combines connected devices, member engagement, artificial-intelligence insights and provider-backed clinical care. The company serves health plans, health systems and employers across diabetes, hypertension, weight management, musculoskeletal and behavioral health.

Business model and competitive setting

DarioHealth is an Israel-based digital-health company serving employers, health plans and health systems with connected devices, AI-driven insights, personalized engagement and clinical care for multiple chronic conditions. Its platform spans consumer engagement and payer-oriented care, supported by more than 13 billion proprietary longitudinal healthcare data points, according to the company. A Meticulous Research market brief places DarioHealth among prescription digital-therapeutic developers, while Hinge Health, Omada Health and Teladoc Health are identified as scaled virtual chronic-care providers. DarioHealth therefore competes in a broader digital-care market while emphasizing a multi-condition platform and provider-backed delivery.